Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.301 USD | +0.33% | -10.15% | -27.64% |
Sales 2024 * | 7.3M 5.29M | Sales 2025 * | 9.12M 6.62M | Capitalization | 2.51M 1.82M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.34 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.27 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc.
1 day | +0.33% | ||
1 week | -10.15% | ||
Current month | -17.31% | ||
1 month | -15.24% | ||
3 months | -15.21% | ||
6 months | -51.35% | ||
Current year | -27.64% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.301 | +0.33% | 131,018 |
24-04-17 | 0.3 | -1.78% | 260,209 |
24-04-16 | 0.3054 | -4.16% | 806,885 |
24-04-15 | 0.3187 | -3.28% | 103,193 |
24-04-12 | 0.3295 | -1.64% | 67,463 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.64% | 1.82M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-0.44% | 21.66B | |
-18.35% | 20.77B | |
-7.45% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- INM Stock